Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
Condition(s):Toxoplasmosis, Cerebral; HIV InfectionsLast Updated:October 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Toxoplasmosis, Cerebral; HIV InfectionsLast Updated:October 28, 2021Completed
Condition(s):Pneumonia, Pneumocystis Carinii; HIV InfectionsLast Updated:March 1, 2011Completed
Condition(s):MalariaLast Updated:March 19, 2020Completed
Condition(s):Plasmodium Falciparum InfectionLast Updated:August 11, 2014Completed
Condition(s):MalariaLast Updated:December 9, 2015Completed
Condition(s):Bacterial Infections; Pneumonia, Pneumocystis Carinii; HIV InfectionsLast Updated:November 4, 2021Completed
Condition(s):BioavailabilityLast Updated:May 5, 2022Completed
Condition(s):MalariaLast Updated:July 15, 2019Completed
Condition(s):Malaria; FalciparumLast Updated:April 5, 2011Completed
Condition(s):Malaria, FalciparumLast Updated:August 19, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.